cytomegalovirus

Cytomegalovirus CMV herpes herpesvirus virus
Biotech

Moderna scraps congenital virus program after vax fails ph. 3

While the mRNA-1647 vaccine was well-tolerated, Moderna said, the shot’s ability to prevent infection was well below the company’s target.
Darren Incorvaia Oct 22, 2025 5:15pm
Photo of someone standing on a rock looking off to the left using binoculars

Investors home in on Moderna's RSV, CMV prospects

Feb 22, 2024 10:09am
Stop sign

Hookipa halts spending on CMV vaccine after seeing phase 2 data

Mar 15, 2023 9:14am
Cytomegalovirus CMV herpes herpesvirus virus

New antiviral class could halt treatment-resistant viruses

May 16, 2022 3:10pm